Objective: The evaluation of the effects of repeated antenatal corticosteriod (CS) medication on birth size and size at the age of 4 years.
Methods: 82 children exposed to CS initially between 26 and 28 weeks of gestation were matched with 82 controls of the same gestational age and sex.
Results: No differences were observed between the CS and control groups with regard to weight, head circumference, and length at birth and at the age of 4 years.
Conclusions: Our study failed to demonstrate that repetitive antenatal medication with CS in order to induce lung maturation has a negative impact on intrauterine growth and growth in early childhood.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000053014 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!